BioBlast Pharma Announces Positive Preclinical for its Read-through Drug Candidate dne June 26, 2015 BioBlast Pharma smn protein SMN2 spinal muscular atrophy spinal muscular atrophy cure spinal muscular atrophy research +
Data From ISIS-SMN Rx Phase 2 Study in Infants With Spinal Muscular Atrophy Looking Good dne June 18, 2015 ISIS Pharmaceuticals ISIS SMNrx SMA type 1 spinal muscular atrophy spinal muscular atrophy cure +
Results of Novartis' High Throughput Screening Campaign dne June 10, 2015 Novartis smn protein SMN2 spinal muscular atrophy spinal muscular atrophy cure spinal muscular atrophy research +